Management of Anxiety Associated with Alcohol Discontinuation

Primary Pharmacological Treatment

The American Association for the Study of Liver Diseases recommends benzodiazepines as the gold standard first-line treatment for anxiety associated with alcohol withdrawal, with long-acting agents like diazepam (5-10 mg IV/IM every 6-8 hours) or chlordiazepoxide (25-100 mg orally every 4-6 hours) preferred for most patients 1, 2, 3
Long-acting benzodiazepines, such as diazepam, provide superior anxiety control and seizure protection, and are the preferred agents due to their long duration of action, providing smoother withdrawal coverage and better protection against both anxiety and seizures 1, 3, 4
For patients with hepatic dysfunction, advanced age, respiratory compromise, or obesity, lorazepam (1-4 mg every 4-8 hours) should be chosen due to safer pharmacokinetics 1, 2, 3, 5

The American College of Gastroenterology recommends thiamine administration as non-negotiable for all patients with alcohol withdrawal, with a dosage of 100-300 mg/day orally for standard cases 3, 4, 5
Parenteral thiamine should be used for high-risk patients or those with suspected Wernicke's encephalopathy, and thiamine should always be given before any dextrose-containing solutions to prevent precipitating Wernicke's encephalopathy 3, 5

For anxiety that persists despite adequate benzodiazepine dosing, haloperidol or other antipsychotics should be added as adjuncts only in cases of delirium tremens refractory to benzodiazepines, and never used as monotherapy — as they lower seizure threshold and worsen outcomes without benzodiazepines 3, 5

The National Institute on Alcohol Abuse and Alcoholism advises against using anticonvulsants (phenytoin, carbamazepine) to prevent withdrawal seizures, as they are ineffective for this indication and may worsen outcomes 3
Disulfiram should be avoided in patients with severe alcoholic liver disease due to hepatotoxicity risk, and naltrexone should not be used during acute withdrawal in patients with liver disease 1, 4

The American Psychiatric Association recommends assessing whether anxiety is independent or concurrent with alcohol dependence, as concurrent anxiety disorders typically disappear once the patient is weaned off alcohol and do not require specific psychiatric treatment, while independent anxiety disorders will need specific psychiatric treatment beyond withdrawal management 1, 2

The Society of Hospital Medicine recommends inpatient admission for patients with severe withdrawal symptoms (delirium, seizures, delirium tremens), concurrent serious physical or psychiatric disorders, or a history of complicated withdrawal or inadequate social support 3